2-210477748-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001122633.3(CPS1):​c.-34G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0137 in 1,613,276 control chromosomes in the GnomAD database, including 272 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.013 ( 31 hom., cov: 32)
Exomes 𝑓: 0.014 ( 241 hom. )

Consequence

CPS1
NM_001122633.3 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.601
Variant links:
Genes affected
CPS1 (HGNC:2323): (carbamoyl-phosphate synthase 1) The mitochondrial enzyme encoded by this gene catalyzes synthesis of carbamoyl phosphate from ammonia and bicarbonate. This reaction is the first committed step of the urea cycle, which is important in the removal of excess urea from cells. The encoded protein may also represent a core mitochondrial nucleoid protein. Three transcript variants encoding different isoforms have been found for this gene. The shortest isoform may not be localized to the mitochondrion. Mutations in this gene have been associated with carbamoyl phosphate synthetase deficiency, susceptibility to persistent pulmonary hypertension, and susceptibility to venoocclusive disease after bone marrow transplantation.[provided by RefSeq, May 2010]
LANCL1 (HGNC:6508): (LanC like glutathione S-transferase 1) This gene encodes a loosely associated peripheral membrane protein related to the LanC family of bacterial membrane-associated proteins involved in the biosynthesis of antimicrobial peptides. This protein may play a role as a peptide-modifying enzyme component in eukaryotic cells. Previously considered a member of the G-protein-coupled receptor superfamily, this protein is now in the LanC family. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Nov 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 2-210477748-G-A is Benign according to our data. Variant chr2-210477748-G-A is described in ClinVar as [Benign]. Clinvar id is 380167.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-210477748-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0133 (2023/152270) while in subpopulation NFE AF = 0.0153 (1038/68032). AF 95% confidence interval is 0.0145. There are 31 homozygotes in GnomAd4. There are 1119 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 31 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CPS1NM_001122633.3 linkc.-34G>A 5_prime_UTR_variant Exon 1 of 39 NP_001116105.2 P31327-1Q6PEK7
CPS1NM_001369257.1 linkc.-154G>A 5_prime_UTR_variant Exon 1 of 40 NP_001356186.1
LANCL1XM_005246243.3 linkc.-279C>T upstream_gene_variant XP_005246300.1 A0A024R3Z5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CPS1ENST00000430249.7 linkc.-16G>A 5_prime_UTR_variant Exon 1 of 39 1 ENSP00000402608.2 P31327-3
CPS1ENST00000673510.1 linkc.-154G>A 5_prime_UTR_variant Exon 1 of 40 ENSP00000500537.1 P31327-1
CPS1ENST00000673630.1 linkc.-268G>A 5_prime_UTR_variant Exon 1 of 40 ENSP00000501073.1 P31327-1

Frequencies

GnomAD3 genomes
AF:
0.0133
AC:
2023
AN:
152152
Hom.:
31
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00232
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00897
Gnomad ASJ
AF:
0.0600
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.0466
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.0153
Gnomad OTH
AF:
0.0138
GnomAD2 exomes
AF:
0.0152
AC:
3784
AN:
248272
AF XY:
0.0150
show subpopulations
Gnomad AFR exome
AF:
0.00137
Gnomad AMR exome
AF:
0.00657
Gnomad ASJ exome
AF:
0.0598
Gnomad EAS exome
AF:
0.000167
Gnomad FIN exome
AF:
0.0424
Gnomad NFE exome
AF:
0.0165
Gnomad OTH exome
AF:
0.0186
GnomAD4 exome
AF:
0.0138
AC:
20148
AN:
1461006
Hom.:
241
Cov.:
29
AF XY:
0.0136
AC XY:
9920
AN XY:
726744
show subpopulations
African (AFR)
AF:
0.00197
AC:
66
AN:
33478
American (AMR)
AF:
0.00674
AC:
301
AN:
44686
Ashkenazi Jewish (ASJ)
AF:
0.0604
AC:
1578
AN:
26110
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39694
South Asian (SAS)
AF:
0.00177
AC:
152
AN:
86118
European-Finnish (FIN)
AF:
0.0383
AC:
2046
AN:
53376
Middle Eastern (MID)
AF:
0.0323
AC:
186
AN:
5766
European-Non Finnish (NFE)
AF:
0.0134
AC:
14846
AN:
1111424
Other (OTH)
AF:
0.0161
AC:
971
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
877
1754
2631
3508
4385
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
532
1064
1596
2128
2660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0133
AC:
2023
AN:
152270
Hom.:
31
Cov.:
32
AF XY:
0.0150
AC XY:
1119
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.00231
AC:
96
AN:
41556
American (AMR)
AF:
0.00896
AC:
137
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0600
AC:
208
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5182
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4820
European-Finnish (FIN)
AF:
0.0466
AC:
494
AN:
10602
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.0153
AC:
1038
AN:
68032
Other (OTH)
AF:
0.0137
AC:
29
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
102
204
306
408
510
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0160
Hom.:
38
Bravo
AF:
0.0100
Asia WGS
AF:
0.00144
AC:
6
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 14, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
6.1
DANN
Benign
0.68
PhyloP100
-0.60
PromoterAI
-0.016
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Loading publications...

Other links and lift over

dbSNP: rs111491997; hg19: chr2-211342472; API